Sarz Maxwell MD FASAM www. AnyPositiveChange.org.

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
Introduction to Drug Misuse Les Goldman. Objectives Gain basic knowledge of Common current patterns of drug misuse Local referral pathways Available treatments.
Recognition, Response and Administration of Naloxone (Narcan)
Education and Training Module for Ohio EMS Developed in the 1960s Opioid antagonist Emergent overdose treatment in the hospital and prehospital settings.
WREMAC BLS Naloxone In-service
Deaths Avoided With Naloxone What is Naloxone? Naloxone commonly known as Narcan is a medication that can reverse and overdose caused by an opioid drug.
DBHDS Vision: A life of possibilities for all Virginians Treatment for Opioid Addiction Public Community Treatment in Virginia Virginia Heroin and Prescription.
Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS.
Opioid Rescue Kits for Porter County Sheriff’s Department.
San Francisco Bay Area Drug Trends and Effective Intervention Strategies Alice Gleghorn, Ph.D County Alcohol and Drug Program Administrator San Francisco.
Opioid Overdose Prevention South Boston HOPE Initiative.
Swinomish Wellness Program
STATEWIDE OPIOID ANTAGONIST COMMUNITY ACCESS PROGRAM INTRANASAL NALOXONE ADMINISTRATION TRAINING MODULE Vermont Statewide Opioid Antagonist Program.
Project Coordinator Overdose Prevention Project, Prevention Point Pittsburgh Alice Bell, LCSW.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
Sublingual Buprenorphine and Pain
Presented By: Mary Wheeler Street Outreach Coordinator CAB Health and Recovery Services Inc., Lynn, MA.
Northeast Tennessee Naloxone Pilot David Kirschke, MD Medical Director Northeast Region Health Office.
Copyright Alcohol Medical Scholars Program 1 Opioid Agonist Treatment: “Trading one substance for another?” Joseph Sakai, M.D.
The Take Home Naloxone Program in British Columbia, Canada Erin Gibson, Despina Tzemis, Jane Buxton BC Centre for Disease Control Harm Reduction Program.
Overdose deaths from street heroin and prescribed methadone: analysis and prevention options Professor John Strang National Addiction Centre, London, UK.
Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition
Implementation in Ohio’s Regional Psychiatric Hospitals.
Naloxone (Narcan) A true opioid overdose antidote.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
The Opiate Crisis in Rural America Carol A. Cunningham, M.D., FAAEM, FACEP State Medical Director Ohio Department of Public Safety, Division of EMS Associate.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
OPIOIDS I. Where do they come from? –poppy plant: from middle east and Asia –dried sap from plant is opium; cultivated annually BUT plant produces drug.
YOU Can Help Someone Overdosing on an Opiate HHCLA Overdose Prevention and Response Program.
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
Overdose: A major preventable cause of death in Eastern Europe and Central Asia Shona Schonning.
Buprenorphine Therapy in Primary Care: One Prescriber’s Experience Pittsburgh, PA August 24, 2005 Melinda Campopiano, M.D. Baron Edmond de Rothschild Chemical.
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
MBEMSC /PIER Committee
Allegheny County Overdose Prevention Coalition
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
NALOXONE Presented by The RASE Project. Scope Of The Problem Opiate overdose is a major public health problem in the United States. Overdoses have increased.
Saving Lives- A Case for Stocking Narcan in our School Health Offices
Buprenorphine {Suboxone®, Subutex®}
Ill Naloxone February 7 th, 2015 Tom Rafferty. Opioid Dependency & Overdose Emergency Interventions For Overdose Future Of Naloxone Questions Rescue Kits.
Opiate overdose. Opiate overdose (ONS, 2012) The most common acute cause of drug-related death is opiate overdose. Over half – 596 (57 per cent) - of.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Heroin Overdose Prevention STAY ALIVE ’TIL HELP ARRIVES Ronald RJ Johnson Health Educator Drug Use & HIV/AIDS Prevention HIV/AIDS Program Public Health.
Welcome to Naloxone Training for Opioid Overdose Reversal.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
The Highs and Lows of Relapse and Recovery in Opioid Use Disorder
Recognition, Response and Administration of Naloxone (Narcan)
Narcan.
Overdose Prevention, Recognition and Response
The Opioid Epidemic and Naloxone CTSMA 57th Annual Conference
Medication-Assisted Therapy at Coleman Profession Services
How to use Naloxone to save a life.
Opioid Overdose Responder Training
Overdose Prevention and Management
First Responder Naloxone Grant Webinar
QC Harm Reduction Opioid Overdose Reversal Training
Naloxone in North Carolina
Act Naloxone Availability
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
QC Harm Reduction Opioid Overdose Reversal Training
Human Dignity and Harm Reduction
Medically assisted treatment
OVERDOSE AWARENESS & NALOXONE TRAIN THE TRAINER
Presentation transcript:

Sarz Maxwell MD FASAM www. AnyPositiveChange.org

“… he was nodding and then I looked over and he was … well, there’s a smell, you know? I knew he was dead. And I didn’t know what to do, I just parked the car and got on the bus. He was dead. What could I do?”

Medical Precedent

 Pure opiate antagonist  >40 years experience by emergency personnel for OD reversal  Only effect is blockade of opiate receptor  Not addictive; no potential for abuse  No side effects except precipitation of withdrawal  Dose- and delivery-sensitive

OptionsAdvantagesDisadvantages Single-dose pre-loaded syringe Pre-measured No add’l equipment Cost (~$15 USD /dose) Fragile apparatus Single dose Intranasal atomizer No needles Premeasured Cost (~10 USD /dose) Slightly less efficacy Single dose Multi-dose multi-use 10cc vial Cost (~$0.27 /dose) Multiple doses Very portable / durable Need add’l needles ?contamination?

 Average heroin user has witnessed 4 OD’s, at least 1 of them fatal  Deaths of peers & personal experience with OD do not ‘teach’ actively-using heroin addicts to stop using heroin  Heroin addicts are interested in helping other addicts in trouble

 Participants definitely motivated to intervene in OD situations  Participant focus groups informed program development  Low threshold  Multi-dose vial formulation

 89% approve the idea  92% express willingness to attend training session  Concerns:  Police harrassment & legality of naloxone possession  Fear of dopesickness  Dose- and delivery-sensitive Wright et al 2006 UK Kerr et all 2008 Australia

“I was just freakin’ out, thinking: ‘I wish I knew how to do CPR’… and I was like, ‘Oh, why don’t I know this?’”

 Death of CRA co-founder in 1997  Begin distributing naloxone in 1997  2000 actively expanding program  Train all CRA operatives to educate and distribute

 US law allows a prescription to be written when a doctor-patient relationship exists  Chart  Documentation of education RE prescription  Medical director trained CRA operatives to educate & distribute  Intake form developed with brief history, checklist for education, and standing order  OEND occurred at all 22 weekly SEP sites plus cell phone on-call  Participants quickly became distributors

 OD Prevention  Early Recognition › Unresponsive › Before cyanosis  Rescue Breathing  Naloxone administration › 1 cc (0.4 mg) IM › > 1” needle › Multi-use vial  Aftercare › Do not use more opiate!  High will return in min › Return of OD › Transport for medical f/u

 Age > 34  Using in combination with other drugs  Alcohol  Cocaine

PONS Respiratory Centre Opiates depress respiratory drive MEDULLA Cardiac Centre Cocaine stimulates heartbeat, blood pressure

 Mixing drugs  Using alone  Recent period of abstinence – as brief as 3 days will decrease tolerance  Detox program  Incarceration

… I put myself in detox and I got out, shot up a bag … and he was with me, thank god, because I went out.” “He got out of the joint… came back, thought he had the same tolerance… but he didn’t…

DrugDurationpotency Methadone24 hr++++ Heroin6 – 8 hr+++++ Oxycodone3 – 6 hr+++++ Codeine3 – 4 hr+ Demerol2 – 4 hr++ Morphine3 – 6 hr+++ Fentanyl2 - 4 hr

low self esteem + stigma nihilism + hopelessness for the future

stigmaHopeFuture-orientation NALOXONEEmpowerment+ New Message: “it matters if you live or die” community, community,altruism

“I did something that made a difference. The whole world can’t see it but I know it made a difference. And that’s important… to me.”

 Statewide program supported by state DPH  Operating in 13 communities  SEPs, drop-in centers, treatment programs ( detox, OTP, residential tx, inpt), ER, home visits, street outreach  >9000 enrolled, ~1000 reversals (11%)

 Top 3 most common sites for OTP patient naloxone refills:  Needle Exchange Program (40%)  Drop-in Center (30%)  Methadone Clinic (9%) Slide courtesy Maya Doe-Simkins

 70 patients with opioid dependence syndrome in abstinence-based program trained & given naloxone  6 mos later, participants had retained knowledge, still had the naloxone, but none had used it  Transportability  Stigma  Fear of police Harm Reduct J, 2009 Sep 24; 6:26

 Low threshold – on demand, easily accessible, minimal paperwork  Education – duration; by whom  Venue – user-friendly  Formulation – simple, durable  Doses and Refills – multiple doses  OD relapse  Multiple simultanerous victims  Abundance >> Confidence

“It used to be, overdose, you always talked about it in past tense: ‘I HAD a friend who OD’d.’ Now, overdose is in the present tense: ‘I HAVE a friend who OD’d last week’. Naloxone did that.”

 Dan Bigg  Karen Stanczykiewiz  Greg Scott  Suzanne Carlberg – Racich  John Gutenson  Susie Gualtieri  Sharon Sereda  Esther, Cheryl, Cliff, Andrew …  All of our courageous participants, who make this program work

the end(s) www. AnyPositiveChange.org yahoo.com